全部资讯｜CELL INTELLIGENCE

Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review.

PubMed 2026/05/05 发表Breast Cancer (Dove Med Press)Q2 · IF 3.6（JCR 2025）

Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers.

PubMed 2025/04/19 发表Biomed Pharmacother

Augmenting the Antitumor Efficacy of Natural Killer Cells via SynNotch Receptor Engineering for Targeted IL-12 Secretion.

PubMed 2024/03/28 发表Curr Issues Mol BiolQ2 · IF 4.1（JCR 2025）

Understanding the Interplay of CAR-NK Cells and Triple-Negative Breast Cancer: Insights from Computational Modeling.

PubMed 2024/01/19 发表Bull Math BiolQ2 · IF 2.3（JCR 2025）

Advances in natural killer cell therapies for breast cancer.

PubMed 2023/06/06 发表Immunol Cell BiolQ3 · IF 3.3（JCR 2025）

Emerging Targeted Therapies for HER2-Positive Breast Cancer.

PubMed 2023/03/26 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

The role of the natural killer (NK) cell modulation in breast cancer incidence and progress.

PubMed 2022/08/25 发表Mol Biol RepQ3 · IF 3.2（JCR 2025）

Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances.

PubMed 2022/06/28 发表J Cell Mol MedQ2 · IF 4.7（JCR 2025）

全部资讯 8